HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 3 of 3
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleKubo, Kimitoshi; Kawakami, Hiroshi; Kuwatani, Masaki; Nishida, Mutsumi; Kawakubo, Kazumichi; Kawahata, Shuhei; Taya, Yoko; Kubota, Yoshimasa; Amano, Toraji; Shirato, Hiroki; Sakamoto, NaoyaLiver elasticity measurement before and after biliary drainage in patients with obstructive jaundice : a prospective cohort studya prospective cohort study-BMC gastroenterology-8-Jul-2016
article (author version)Takashina, Taichi; Asahina, Hajime; Oizumi, Satoshi; Yamada, Noriyuki; Harada, Masao; Takamura, Kei; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Ogi, Takahiro; Morikawa, Naoto; Kinoshita, Ichiro; Honda, Ryoichi; Nakano, Kosuke; Kanazawa, Kenya; Amano, Toraji; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)-International journal of clinical oncology-Dec-2018
article (author version)Ikezawa, Yasuyuki; Asahina, Hajime; Oizumi, Satoshi; Watanabe, Masahiro; Takamura, Kei; Kawai, Yasutaka; Yamada, Noriyuki; Harada, Toshiyuki; Kinoshita, Ichiro; Fujita, Yuka; Miyauchi, Eisaku; Ogi, Takahiro; Amano, Toraji; Furuta, Megumi; Sakakibara-Konishi, Jun; Nishihara, Hiroshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)Cancer chemotherapy and pharmacology-Nov-2017
Showing results 1 to 3 of 3

 

Feedback - Hokkaido University